ReferIndia News FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

ReferIndia News

Sponsored

🧠 सिर्फ कुछ मिनटों में बनाएं अपनी वेबसाइट – वो भी AI की मदद से

Create Website
News Image

FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

Published on: Sept. 24, 2025, 1:21 a.m. | Source: Devdiscourse

The FDA has approved leucovorin, also known as folinic acid, for managing symptoms related to autism. The approval comes amid data on its efficacy for cerebral folate deficiency, associated with autism. Previously marketed as Wellcovorin, it was withdrawn not due to safety issues but business reasons.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact